Lafta dhuuxa lafta waa cudur naadir ah oo ku dhaca unugyada unugyada hematopoietic dhuuxa. Waxay ka faa'iideystaan daroogada JAK2 inhibitor: astaamaha astaamaha, badbaadada muddada dheer, iyo tayada nolosha oo la hagaajiyo. Si kastaba ha noqotee, laba ama seddex sano ka dib daaweynta kadib, bukaanjiifka qaar ayaa ku dhacda fiditaanka B-cell lymphoma. Iyadoo lala kaashanayo cilmi-baarayaasha Vienna, MedUni iyo Vetmeduni, JAK2 inhibitors waxay toosiyeen "lymphoma" hurdo iyo kansar ku jira dhuuxa lafta markii ugu horeysay.
Using bone marrow biopsy at the beginning of the disease, 16% of patients with myelofibrosis were found to have dormant aggressive lymphoma. In about 6% of these patients, when stimulated with JAK2 inhibitors, it bursts. According to hematologists, if sensitive molecular biology techniques are used to actively search for latent lymphoma, it is possible to detect dormant lymphoma. This is the best predictive tool that allows us to screen out 16% of patients identified as high-risk patients before treatment with JAK2 inhibitors.
Waxaa lagu cadeeyay qaabka jiirka in jiir lagu sameeyay qalliin dhuuxa lafta uu sidoo kale sameeyay lymphoma. Wadashaqeynta dhinacyada badan ayaa tusaale fiican u ah sida cilmi baarista guud ahaan u furmay iyo muhiimada isdhaafsiga xogta ee daawada. Talaabada xigta: aruurinta kiisaska caalamiga ah iyo xogta laxiriira waxay bilaabeen inay sii hagaajiyaan badqabka dawada, cilmi baarayaashuna waxay si dhaw ulashaqeeyaan shirkadaha dawooyinka soo saara daawooyinkaan caadiga ah. Samee buundo deg deg ah, hufan oo gogol-xaadh ah oo udhaxeysa moodellada jiirka iyo daah-furnaanta kiliinikada, iyadoo si fiican la isugu darayo cilmi-baarista aasaasiga ah, shaqada hore iyo tan caafimaad si looga faa'iideysto bukaannada kansarka.
